Single cell multi-omic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma

被引：0

作者：

Harrison, Simon ^{[1
,2
]}

Riley, Caroline Hasselbalch ^{[3
]}

Manier, Salomon ^{[4
]}

Yoon, Sung-Soo ^{[5
]}

Pinto, Antonio ^{[6
]}

Cazaubiel, Titouan ^{[7
]}

Guidetti, Anna ^{[8
]}

Popat, Rakesh ^{[9
]}

Touzeau, Cyrille ^{[10
]}

Ocio, Enrique ^{[11
]}

Offner, Fritz ^{[12
]}

Rodriguez-Otero, Paula ^{[13
]}

Rizzello, Ilaria ^{[14
,15
]}

Mateos, Maria-Victoria ^{[16
]}

Broeske, Ann-Marie ^{[17
]}

Dekhtiarenko, Iryna ^{[18
]}

Dimier, Natalie ^{[19
]}

Eckmann, Jan ^{[17
]}

Helms, Hans-Joachin ^{[20
]}

Jacob, Wolfgang ^{[17
]}

Schneider, Meike ^{[20
]}

Sleiman, Nassim ^{[20
]}

Weisser, Martin ^{[17
]}

Carlo-Stella, Carmelo ^{[21
,22
]}

机构：

[1] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[3] Rigshospitalet, Copenhagen, Denmark

[4] CHU Lille, Lille, France

[5] Seoul Natl Univ, Coll Med, Seoul, South Korea

[6] Ist Nazl Tumori IRCCS Fondazione G Pascale, Naples, Italy

[7] CHU Bordeaux, Bordeaux, France

[8] Ist Nazl Tumori, Milan, Italy

[9] NHS Univ Coll London Hosp, London, England

[10] CHU Nantes, Nantes, France

[11] Marques Valdecilla Univ Hosp, Santander, Spain

[12] Univ Ziekenhuis Gent, Ghent, Belgium

[13] Clin Univ Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain

[14] Univ Bologna, Ist Ematol Seragnoli, IRCCS Azienda Osped, Bologna, Italy

[15] Univ Bologna, Bologna, Italy

[16] Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain

[17] Roche Innovat Ctr Munich, Penzberg, Germany

[18] Roche Innovat Ctr Zurich, Zurich, Switzerland

[19] Roche Innovat Ctr Welwyn, Welwyn Garden City, England

[20] Roche Innovat Ctr Basel, Basel, Switzerland

[21] Humanitas Univ, Dept Oncol & Hematol, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy

[22] Humanitas Univ, Dept Biomed Sci, Rozzano, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA-04

引用

页码：S3 / S3

页数：1

共 50 条

[41] Chimeric antigen receptor T-cell therapy for multiple myeloma
Naoki Hosen
International Journal of Hematology, 2020, 111 : 530 - 534
[42] Subsequent anti-myeloma therapy after maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) treatment in patients with relapsed/refractory multiple myeloma
Chen, Dongjian
Wang, Xiaoxiang
Chen, Zhi
Jiang, Songfu
Jiang, Hua
Fu, Weijun
Xiang, Fang
Sun, Xuedong
Du, Juan
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E478 - E481
[43] OVERALL RESPONSE AND COMPLETE RESPONSE WITH ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) : A SYSTEMATIC REVIEW AND META-ANALYSIS
Aggarwal, S.
Bela, A.
Topaloglu, O.
VALUE IN HEALTH, 2020, 23 : S25 - S25
[44] Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China
Wang, Baiyan
Liu, Jie
Zhao, Wan-Hong
Chen, Yin-Xia
Cao, Xing-Mei
Yang, Yun
Zhang, Yi-Lin
Wang, Fang-Xia
Zhang, Peng-Yu
Lei, Bo
Gu, Liu-Fang
Wang, Jian-Li
Fan, Frank Xiao-Hu
Zhang, Wang-Gang
He, Ai-Li
BLOOD, 2020, 136
[45] Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement
Zhang, Ying
Zhang, Changfeng
Zhou, Jin
Zhang, Jingren
Chen, Xiaochen
Chen, Jia
Wang, Pu
Sun, Xiuli
Lou, Xiaoyan
Qi, Wei
Kang, Liqing
Yu, Lei
Wu, Depei
Li, Caixia
FRONTIERS IN IMMUNOLOGY, 2021, 12
[46] Gamma secretase inhibition increases recognition of multiple myeloma by BCMA-specific chimeric antigen receptor modified T cells
Hill, Tyler
Pont, Margot
Abbott, Joe
Kelliher, Jessica
Salter, Alexander
Liu, Steven
Green, Damian
Riddell, Stanley
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[47] Prophylaxis and Vaccinations for Infections with BCMA Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma: Usmirc Practice Patterns
Kamboj, Ishita
Snyder, Jordan
Gorsline, Chelsea
Ince, Dilek
Majeed, Aneela
Anwer, Faiz
Shaikh, Hira
Khan, Abdullah Mohammad
Abdallah, Al-Ola
Green, Kimberly M.
Atrash, Shebli
Tiger, Claire Yun Kyoung Ryu
Mewawalla, Prerna
Paul, Barry
Ahmed, Nausheen
BLOOD, 2024, 144 : 5040 - 5041
[48] Outcomes Multiple Myeloma Patients Progressing after BCMA-Directed Chimeric Antigen Receptor T Cell (CART) Therapy
Soomro, Mohammad Ahsen
Atrash, Shebli
Rashid, Aliya
Wesson, William
Hashmi, Hamza
Afrough, Aimaz
Skikne, Barry S.
Lutfi, Forat
Mushtaq, Muhammad Umair
Abdallah, Al-Ola
Ahmed, Nausheen
BLOOD, 2023, 142
[49] CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA
Lee, Dae Hyun
Chandrasekhar, Sanjay Amrith
Jain, Michael
Hansen, Doris
Freeman, Ciara
Alsina, Melissa
Baz, Rachid
Puglianini, Omar Castaneda
Liu, Hien
Blue, Brandon
Davila, Marco L.
Faramand, Rawan
Kumar, Abhishek
Shah, Bijal
Lazaryan, Aleksandr
Khimani, Farhad
Nishihori, Taiga
Bachmeier, Christina
Locke, Frederick
Oliveira, Guilherme Henrique
Alomar, Mohammed
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1933 - 1933
[50] Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Identifies a T-Cell Population That Correlates with Clinical Outcomes
de Mel, Sanjay
Scolnick, Jonathan Adam
Yong, Chern Han
Xu, Stacy
Soekojo, Cinnie Yentia
Song, Fangfang
Ooi, Melissa
Chng, Wee Joo
BLOOD, 2022, 140 : 4336 - 4337

← 1 2 3 4 5 →